BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22491777)

  • 1. MRI of superficial soft tissue masses: analysis of features useful in distinguishing between benign and malignant lesions.
    Calleja M; Dimigen M; Saifuddin A
    Skeletal Radiol; 2012 Dec; 41(12):1517-24. PubMed ID: 22491777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of tumor-fascia relationship in superficial soft tissue masses on magnetic resonance imaging.
    Iwai T; Hoshi M; Oebisu N; Aono M; Takami M; Ieguchi M; Nakamura H
    PLoS One; 2018; 13(12):e0209642. PubMed ID: 30596710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating benign and malignant soft tissue masses by magnetic resonance imaging: role of tissue component analysis.
    Chen CK; Wu HT; Chiou HJ; Wei CJ; Yen CH; Chang CY; Chen WM
    J Chin Med Assoc; 2009 Apr; 72(4):194-201. PubMed ID: 19372075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and diagnostic relevance of chemical shift artefact in the magnetic resonance imaging characterisation of superficial soft tissue masses.
    Saifuddin A; Siddiqui S; Pressney I; Khoo M
    Br J Radiol; 2020 Apr; 93(1108):20190828. PubMed ID: 31834812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI of soft-tissue masses: the relationship between lesion size, depth, and diagnosis.
    Datir A; James SL; Ali K; Lee J; Ahmad M; Saifuddin A
    Clin Radiol; 2008 Apr; 63(4):373-8; discussion 379-80. PubMed ID: 18325355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small (≤5 cm) soft tissue tumors of the extremity and superficial trunk: MRI features and demographic characteristics associated with malignancy.
    Jin K; Yoon MA; Kim DY
    Acta Radiol; 2023 May; 64(5):1886-1895. PubMed ID: 36471487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small soft tissue masses indeterminate at imaging: histological diagnoses at a tertiary orthopedic oncology clinic.
    Pham K; Ezuddin NS; Pretell-Mazzini J; Subhawong TK
    Skeletal Radiol; 2019 Oct; 48(10):1555-1563. PubMed ID: 30903259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue masses: distribution of entities and rate of malignancy in small lesions.
    Gassert FG; Gassert FT; Specht K; Knebel C; Lenze U; Makowski MR; von Eisenhart-Rothe R; Gersing AS; Woertler K
    BMC Cancer; 2021 Jan; 21(1):93. PubMed ID: 33482754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma group.
    Crombé A; Brisse HJ; Ledoux P; Haddag-Miliani L; Bouhamama A; Taieb S; Le Loarer F; Kind M
    Eur Radiol; 2019 Jun; 29(6):3170-3182. PubMed ID: 30560359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a risk assessment model to differentiate malignant and benign musculoskeletal soft-tissue masses on magnetic resonance imaging.
    Obaid H; Vassos N; Adams SJ; Bryce R; Donuru A; Sinclair N
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):9-17. PubMed ID: 31793194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential diagnosis of trunk and extremity dermal and sub-dermal lesions referred to a musculoskeletal oncology service.
    Saifuddin A; Ali S; Sabahuddin A; Malhotra K; Khoo M
    Clin Imaging; 2021 Oct; 78():51-59. PubMed ID: 33765643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination.
    Kalayanarooj S
    J Med Assoc Thai; 2008 Jan; 91(1):74-81. PubMed ID: 18386548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft tissue masses with "cyst-like" appearance on MR imaging: Distinction of benign and malignant lesions.
    Harish S; Lee JC; Ahmad M; Saifuddin A
    Eur Radiol; 2006 Dec; 16(12):2652-60. PubMed ID: 16670867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small, superficial, indeterminate soft-tissue lesions as suspected sarcomas: is primary excision biopsy suitable?
    Khoo M; Pressney I; Hargunani R; Saifuddin A
    Skeletal Radiol; 2017 Jul; 46(7):919-924. PubMed ID: 28361352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging differentiation of malignant soft tissue tumors from peripheral schwannomas with large size and heterogeneous signal intensity.
    Zhang Z; Deng L; Ding L; Meng Q
    Eur J Radiol; 2015 May; 84(5):940-6. PubMed ID: 25736017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral vascular lesions in adults referred to MRI/MRA: Multivariable analysis of imaging features to help differentiate benign vascular anomalies from malignancies.
    Zhao K; Melamud K; Hindman N
    Clin Imaging; 2022 Nov; 91():45-51. PubMed ID: 35988473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and diagnostic significance of fluid-fluid levels in soft-tissue neoplasms.
    Alyas F; Lee J; Ahmed M; Connell D; Saifuddin A
    Clin Radiol; 2007 Aug; 62(8):769-74; discussion 775. PubMed ID: 17604765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading of subcutaneous soft tissue tumors by means of their relationship with the superficial fascia on MR imaging.
    Galant J; Martí-Bonmatí L; Soler R; Saez F; Lafuente J; Bonmatí C; Gonzalez I
    Skeletal Radiol; 1998 Dec; 27(12):657-63. PubMed ID: 9921926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of diffusion-weighted imaging to conventional MRI for predicting fascial involvement of soft tissue sarcomas.
    Yoon MA; Chee CG; Chung HW; Song JS; Lee JS; Kim W; Lee MH; Lee SH; Shin MJ
    Eur Radiol; 2019 Apr; 29(4):1863-1873. PubMed ID: 30324391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.